发明授权
- 专利标题： Dihydropyrimidinones
- 专利标题（中）： 二氢嘧啶酮
-
申请号： US12770802申请日： 2010-04-30
-
公开(公告)号： US08461160B2公开(公告)日： 2013-06-11
- 发明人: David Banner , Hans Hilpert , Roland Humm , Harald Mauser , Alexander V. Mayweg , Fabienne Ricklin , Mark Rogers-Evans
- 申请人： David Banner , Hans Hilpert , Roland Humm , Harald Mauser , Alexander V. Mayweg , Fabienne Ricklin , Mark Rogers-Evans
- 申请人地址： US NJ Nutley
- 专利权人： Hoffmann-La Roche, Inc.
- 当前专利权人： Hoffmann-La Roche, Inc.
- 当前专利权人地址： US NJ Nutley
- 优先权： EP09159740 20090508
- 主分类号： C07D239/22
- IPC分类号： C07D239/22 ; C07D401/12 ; C07D403/12 ; A61K31/513
摘要：
This invention relates to dihydropyrimidinones of the formula wherein X and R1 to R7 are as defined in the description, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.
公开/授权文献
- US20100286158A1 DIHYDROPYRIMIDINONES 公开/授权日：2010-11-11
信息查询
